JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JCM.01455-08v1
46/10/3426    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Akpaka, P. E.
Right arrow Articles by Rastogi, N.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akpaka, P. E.
Right arrow Articles by Rastogi, N.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, October 2008, p. 3426-3428, Vol. 46, No. 10
0095-1137/08/$08.00+0     doi:10.1128/JCM.01455-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Evaluation of Methods for Rapid Detection of Resistance to Isoniazid and Rifampin in Mycobacterium tuberculosis Isolates Collected in the Caribbean {triangledown}

Patrick Eberechi Akpaka,1* Shirematee Baboolal,1,2 Denise Clarke,2 Lorraine Francis,2 and Nalin Rastogi3

Department of Para-Clinical Sciences, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Trinidad and Tobago,1 Caribbean Epidemiology Centre, Jamaica Boulevard, Port of Spain, Trinidad and Tobago,2 Institut Pasteur de la Guadeloupe, Abymes, Guadeloupe3

Received 29 July 2008/ Accepted 2 August 2008

The rapid identification of drug-resistant strains of Mycobacterium tuberculosis is crucial for the timely initiation of appropriate antituberculosis therapy. The performance of the Genotype MTBDRplus assay was compared with that of the Bactec 460 TB system, a "gold standard" culture-based method. The Genotype MTBDRplus assay was quicker and more cost-effective for the detection of rifampin resistance, but it was not as good for the detection of isoniazid-resistant strains in our setting.


* Corresponding author. Mailing address: Department of Para-Clinical Sciences, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Trinidad & Tobago. Phone: (868) 736-0440. Fax: (868) 663-3797. E-mail: Patrick.Akpaka{at}sta.uwi.edu

{triangledown} Published ahead of print on 13 August 2008.


Journal of Clinical Microbiology, October 2008, p. 3426-3428, Vol. 46, No. 10
0095-1137/08/$08.00+0     doi:10.1128/JCM.01455-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.